CONMED Corporation Total Liabilities
CONMED Corporation total liabilities. Based on the latest financial reports, CONMED Corporation (CNMD) has total liabilities worth $1.30 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CONMED Corporation asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of CONMED Corporation (1986–2025)
Total liabilities of CONMED Corporation from 1986 to 2025. This chart illustrates how CONMED Corporation's total liabilities have evolved over time, based on quarterly financial data.
CONMED Corporation Competitors by Total Liabilities
The table below lists competitors of CONMED Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.19 Billion |
|
Green Cross Corp
KO:006280
|
Korea | ₩1.70 Trillion |
|
Paras Defence and Space Technologies Limited
NSE:PARAS
|
India | Rs2.40 Billion |
|
Nabors Industries Ltd.
NYSE:NBR
|
USA | $2.98 Billion |
|
Smartgroup Corporation Ltd
AU:SIQ
|
Australia | AU$437.33 Million |
|
Taiyuan Heavy Industry Co Ltd
SHG:600169
|
China | CN¥26.57 Billion |
|
Five Star Bancorp
NASDAQ:FSBC
|
USA | $4.90 Billion |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
|
China | CN¥1.04 Billion |
Liability Composition Analysis (1986–2025)
This chart breaks down CONMED Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is CONMED Corporation's balance sheet.
Liquidity & Leverage Metrics
CONMED Corporation Total Liabilities Ratios Explained
CONMED Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CONMED Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CONMED Corporation (1986–2025)
The table below shows the annual total liabilities of CONMED Corporation from 1986 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.29 Billion | -3.79% |
| 2024-12-31 | $1.34 Billion | -8.34% |
| 2023-12-31 | $1.47 Billion | -5.56% |
| 2022-12-31 | $1.55 Billion | +58.28% |
| 2021-12-31 | $980.58 Million | -5.95% |
| 2020-12-31 | $1.04 Billion | -2.07% |
| 2019-12-31 | $1.06 Billion | +50.61% |
| 2018-12-31 | $706.87 Million | -2.71% |
| 2017-12-31 | $726.53 Million | -2.92% |
| 2016-12-31 | $748.41 Million | +41.78% |
| 2015-12-31 | $527.87 Million | +2.12% |
| 2014-12-31 | $516.90 Million | +6.76% |
| 2013-12-31 | $484.19 Million | +1.41% |
| 2012-12-31 | $477.46 Million | +31.71% |
| 2011-12-31 | $362.52 Million | -9.19% |
| 2010-12-31 | $399.21 Million | +4.78% |
| 2009-12-31 | $380.99 Million | -4.74% |
| 2008-12-31 | $399.93 Million | +2.82% |
| 2007-12-31 | $388.95 Million | -7.66% |
| 2006-12-31 | $421.22 Million | -6.56% |
| 2005-12-31 | $450.78 Million | +6.10% |
| 2004-12-31 | $424.84 Million | +14.34% |
| 2003-12-31 | $371.57 Million | +4.61% |
| 2002-12-31 | $355.20 Million | -15.02% |
| 2001-12-31 | $417.97 Million | -6.90% |
| 2000-12-31 | $448.97 Million | -0.43% |
| 1999-12-31 | $450.90 Million | +0.96% |
| 1998-12-31 | $446.60 Million | +11.96% |
| 1997-12-31 | $398.90 Million | +3368.70% |
| 1996-12-31 | $11.50 Million | -74.10% |
| 1995-12-31 | $44.40 Million | +133.68% |
| 1994-12-31 | $19.00 Million | -4.04% |
| 1993-12-31 | $19.80 Million | +518.75% |
| 1992-12-31 | $3.20 Million | -25.58% |
| 1991-12-31 | $4.30 Million | -54.26% |
| 1990-12-31 | $9.40 Million | -18.97% |
| 1989-12-31 | $11.60 Million | +346.15% |
| 1988-12-31 | $2.60 Million | -10.34% |
| 1987-12-31 | $2.90 Million | +16.00% |
| 1986-12-31 | $2.50 Million | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more